MOESM7 of Tracking longitudinal genetic changes of circulating tumor DNA (ctDNA) in advanced Lung adenocarcinoma treated with chemotherapy Xiaohong Han Ying Han Qiaoyun Tan Yu Huang Jianliang Yang Sheng Yang Xiaohui He Shengyu Zhou Yan Song Jinping Pi Lijie Zuo Jiarui Yao Di Wu Zhishang Zhang Yuankai Shi 10.6084/m9.figshare.9962840.v1 https://springernature.figshare.com/articles/journal_contribution/MOESM7_of_Tracking_longitudinal_genetic_changes_of_circulating_tumor_DNA_ctDNA_in_advanced_Lung_adenocarcinoma_treated_with_chemotherapy/9962840 Additional file 7: Figure S3. Predictors of plasma VAFs during platinum-based chemotherapy. Plasma VAFs of mutant genes (A, B and C) and Gene express of ROBO2(D) between tumor and normal in TCGA cohort, and function domain altered in gene ROBO2. Each dot represented one samples. Two truncating mutations (including nonsense, nonstop, frameshift deletion, frameshift insertion and splice site) were indicated with hotpink2 dot, ***p < 0.001, **p < 0.01, *p < 0.05. 2019-10-10 08:55:21 CtDNA Efficacy Chemotherapy Lung adenocarcinoma